EBOS Group Limited (ASX:EBO)
Australia
· Delayed Price · Currency is AUD 35.00
+0.09 (0.26%)
Feb 21, 2025, 4:10 PM AEST
EBOS Group Revenue
EBOS Group had revenue of 5.99B AUD in the half year ending December 31, 2024, a decrease of -2.51%. This brings the company's revenue in the last twelve months to 12.60B, down -0.60% year-over-year. In the fiscal year ending June 30, 2024, EBOS Group had annual revenue of 13.19B with 7.78% growth.
Revenue (ttm)
12.60B
Revenue Growth
-0.60%
P/S Ratio
n/a
Revenue / Employee
2.42M
Employees
4,963
Market Cap
6.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 13.19B | 951.65M | 7.78% |
| Jun 30, 2023 | 12.24B | 1.50B | 14.00% |
| Jun 30, 2022 | 10.73B | 1.53B | 16.64% |
| Jun 30, 2021 | 9.20B | 437.35M | 4.99% |
| Jun 30, 2020 | 8.77B | 1.84B | 26.48% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 16.66B |
| Ansell | 3.00B |
| Mesoblast | 8.85M |
EBOS Group News
- 3 days ago - Ebos Group Ltd (EBOSF) (Q1 2025) Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - GuruFocus
- 3 days ago - Half Year 2025 EBOS Group Ltd Earnings Call Transcript - GuruFocus